HK Stock MarketDetailed Quotes
01858 CHUNLI MEDICAL
- 7.900
- +0.080+1.02%
Market Closed Jul 26 16:08 CST
3.03BMarket Cap9.91P/E (TTM)
8.000High7.820Low326.75KVolume7.920Open7.820Pre Close2.56MTurnover0.34%Turnover Ratio9.89P/E (Static)383.57MShares14.74352wk High0.94P/B751.61MFloat Cap7.82052wk Low0.40Dividend TTM95.14MShs Float62.109Historical High0.397Dividend LFY2.30%Amplitude0.371Historical Low7.849Avg Price250Lot Size5.03%Div YieldTTM5.03%Div Yield LFY
CHUNLI MEDICAL Key Stats
All
YOY
| (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -9.72%277.82M | ---- | -19.75%125.99M | ---- | -4.54%307.72M | ---- | 0.92%156.98M | ---- | 13.76%322.36M |
| Profit adjustment | ||||||||||
| Investment loss (gain) | ---- | -78.01%-12.01M | ---- | -183.00%-10.07M | ---- | ---6.75M | ---- | ---3.56M | ---- | ---- |
| Impairment and provisions: | ---- | 53.95%20.71M | ---- | -28.70%11.96M | ---- | 27.92%13.45M | ---- | 63.90%16.78M | ---- | 68.94%10.51M |
| -Other impairments and provisions | ---- | ---- | ---- | -38.59%8.79M | ---- | ---- | ---- | 49.07%14.31M | ---- | ---- |
| Revaluation surplus: | ---- | -1.27%-9.61M | ---- | -10.60%-4.38M | ---- | ---9.49M | ---- | ---3.96M | ---- | ---- |
| Asset sale loss (gain): | ---- | 84.57%-3.9K | ---- | ---- | ---- | -70.33%-25.31K | ---- | -208.84%-25.31K | ---- | -109.39%-14.86K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 84.57%-3.9K | ---- | ---- | ---- | -70.33%-25.31K | ---- | -208.84%-25.31K | ---- | -109.39%-14.86K |
| Depreciation and amortization: | ---- | 17.66%33.25M | ---- | 28.60%15.63M | ---- | 68.54%28.26M | ---- | 53.31%12.15M | ---- | 10.55%16.77M |
| -Amortization of intangible assets | ---- | 38.14%10.78M | ---- | 57.63%4.63M | ---- | 114.53%7.81M | ---- | 97.28%2.94M | ---- | 39.79%3.64M |
| -Other depreciation and amortization | ---- | ---- | ---- | ---- | ---- | -41.67%128.33K | ---- | 0.00%110K | ---- | 0.00%220K |
| Financial expense | ---- | 100.60%90.11K | ---- | -93.84%-634.25K | ---- | -107.87%-15.01M | ---- | 91.55%-327.2K | ---- | -587.19%-7.22M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -70.22%-193.31M | ---- | -412.51%-128.68M | ---- | -7,093.76%-113.56M | ---- | -112.66%-25.11M | ---- | -106.98%-1.58M |
| Accounts receivable (increase)decrease | ---- | 171.54%294.85M | ---- | 111.08%24.43M | ---- | -83.12%-412.17M | ---- | -159.03%-220.52M | ---- | -100.14%-225.08M |
| Accounts payable increase (decrease) | ---- | -58.85%94.75M | ---- | -337.45%-76.32M | ---- | 642.73%230.27M | ---- | 69.13%-17.45M | ---- | -40.97%31M |
| Special items of business | ---- | -71.72%5.18M | ---- | -11.58%3.11M | ---- | 1.59%18.32M | ---- | 37.44%3.52M | ---- | 408.06%18.03M |
| Adjustment items of business operations | -7.83%-129.61M | 2,132.46%506.53M | 118.00%13.75M | 50.51%-42.08M | -497.38%-120.2M | -84.54%22.69M | -231.72%-76.37M | -618.77%-85.03M | -290.44%-20.12M | -44.94%146.75M |
| Net cash from operations | -7.83%-129.61M | 1,147.85%511.71M | 118.00%13.75M | 52.19%-38.97M | -497.38%-120.2M | -75.11%41.01M | -231.72%-76.37M | -530.17%-81.51M | -290.44%-20.12M | -36.79%164.79M |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | -11.16%5.49M | 65.56%22.37M | 11.79%13.75M | 105.10%13.7M | --6.18M | --13.51M | --12.3M | --6.68M | ---- | ---- |
| Sale of fixed assets | --437.73K | -90.39%6.1K | ---- | ---- | ---- | 43.78%63.5K | 86.76%63.5K | 86.76%63.5K | 86.76%63.5K | -48.89%44.16K |
| Purchase of fixed assets | -1,215.97%-13.5M | -33.48%-33.24M | 39.64%-34.6M | 29.37%-19.14M | 95.17%-1.03M | 87.51%-24.9M | 68.74%-57.32M | 76.00%-27.1M | 59.67%-21.23M | -730.70%-199.41M |
| Acquisition of subsidiaries | ---- | ---6.99M | ---6.99M | ---3.69M | ---9.6M | ---- | ---- | ---- | ---- | ---- |
| Recovery of cash from investments | 8.67%831.3M | 66.57%2.35B | -0.83%1.53B | 65.67%1.52B | --765M | --1.41B | --1.54B | --920M | ---- | ---- |
| Cash on investment | 2.50%-740M | -10.86%-2.41B | 22.14%-1.58B | -11.99%-1.58B | -13.28%-759M | ---2.17B | ---2.03B | ---1.41B | ---670M | ---- |
| Other items in the investment business | ---- | ---- | ---- | ---- | ---- | 52.11%13.72M | ---- | ---- | -61.24%840.72K | 278.60%9.02M |
| Net cash from investment operations | 5,297.49%83.73M | 89.31%-81.56M | 84.76%-81.53M | 87.47%-63.93M | 100.22%1.55M | -300.64%-762.61M | -203.02%-534.95M | -370.44%-510.36M | -1,268.38%-690.33M | -783.83%-190.35M |
| Net cash before financing | 61.33%-45.89M | 159.61%430.16M | 88.91%-67.79M | 82.61%-102.91M | 83.30%-118.65M | -2,723.04%-721.6M | -415.61%-611.32M | -561.04%-591.87M | -1,681.32%-710.45M | -110.69%-25.56M |
| Cash flow from financing activities | ||||||||||
| Dividends paid - financing | ---- | -140.32%-120.06M | -139.92%-120.06M | ---- | ---- | ---49.96M | ---50.04M | ---36.94M | ---- | ---- |
| Absorb investment income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.08B |
| Other items of the financing business | ---- | 85.93%-1.28M | 91.78%-722.7K | 88.93%-132.5K | ---202.69K | -313.55%-9.08M | -421.72%-8.79M | 6.34%-1.2M | ---- | ---2.2M |
| Net cash from financing operations | ---- | -105.53%-121.33M | -105.30%-120.78M | 99.65%-132.5K | ---202.69K | -105.50%-59.04M | -3,391.42%-58.83M | -2,884.11%-38.13M | ---- | 9,140.95%1.07B |
| Effect of rate | ---4.21K | -100.31%-4.21K | -67.29%673.56K | 86.11%673.56K | ---- | 177.70%1.34M | 411.30%2.06M | 176.98%361.91K | -595.59%-218.02K | -29.53%-1.72M |
| Net Cash | 61.39%-45.89M | 139.56%308.82M | 71.86%-188.56M | 83.64%-103.04M | 83.27%-118.85M | -174.48%-780.64M | -457.31%-670.15M | -593.73%-630M | -1,681.32%-710.45M | 361.17%1.05B |
| Begining period cash | 32.26%1.27B | -44.88%957.19M | -44.88%957.19M | -44.88%957.19M | -44.88%957.19M | 151.62%1.74B | 151.62%1.74B | 151.62%1.74B | 151.62%1.74B | 48.68%690.12M |
| Cash at the end | 45.54%1.22B | 32.26%1.27B | -28.00%769.3M | -22.77%854.83M | -18.28%838.34M | -44.88%957.19M | 87.70%1.07B | 84.83%1.11B | 57.75%1.03B | 151.62%1.74B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Daishin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daishin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daishin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg